Standard glutathione capsules are often inefficient because the harsh environment of the digestive system can break the molecule down before it ever reaches the bloodstream
Alternatively, short-chain FAs and MCFAs can leave the intestine and are directly and rapidly released into the portal circulation (Figure 1
A review paper, Therapeutic Applications of Cysteamine and Cystamine in Neurodegenerative and Neuropsychiatric Disease , Bindu Paul and Solomon Snyder of Johns Hopkins proposed using cysteamine and cystamine to treat neurodegenerative diseases such as Alzheimers, Parkinsons, and Huntingtons Diseases as well as autism
In regions with lower breast cancer incidence, death-to-case ratios are high, indicating challenges such as late detection and restricted access to therapies
The peptides acidic residues (glutamate at position 2 and aspartate at position 3) have been proposed to facilitate interactions with chromatin-associated proteins and transcription regulatory complexes, consistent with observed epigenetic effects documented in in-vitro model systems
